Related tables, figures and sidebars

Zocere: Stepping up in stroke

By Lauren Martz
Staff Writer

Published on
Monday, January 20, 2014

Zocere
Inc. may have found a new way to decrease ischemic brain injury in
patients following stroke. The company is developing an injectable,
degradation-resistant version of the neuroprotective STEP protein that could
improve patient outcomes when given up to six hours after the event, longer
than the lone marketed stroke drug.

Read the Rest of this Article

Current Subscribers

Purchase This Article for Individual Use :

Access this BioCentury on BioBusiness article article for your individual use via a permanent link that allows you to read or print the article, and any sub-articles, charts, tables and/or graphs related to this specific story: $100.
The article link will be posted on the purchase transaction web page, and also emailed to you with your purchase confirmation.

Purchase This Article for Limited One-Time Distribution and Posting to Your Website :

Receive a formatted PDF reprint of this article, including any sub-articles, charts, tables and/or graphs related to this specific article, with rights for limited one-time redistribution and posting to your website: $750. Please allow 24-48 hours for delivery.

Purchase Options

Purchase this article for individual use $100 USDPurchase this article for limited one-time distribution and website posting $750 USD

Subscription Option

Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.

Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.